17Dec
Related Posts
16Mar
WT Financial Group (ASX:WTL) acquires Synchronised Business Services
16 March 2022 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen discusses the acquisition of Synchron and what this means for WT.
Read More
03Feb
Novatti Group (ASX:NOV) Dec ’20 quarterly update
03 Feb 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook provides an update on the company's record December quarter results, progress with strategic partners and overseas expansion plans.
Read More
11Aug
Etherstack signs US$20m+ deal with AT&T
11 Aug 2025 - Inside Etherstack’s multi-year partnership with the world’s largest telecom
Read More
11Apr
Altech Batteries (ASX:ATC) launches design for 1 MWh grid storage battery
11 Apr 2023 - Altech Batteries Limited (ASX:ATC) CFO Martin Stein discusses the company's GridPack batteries for the renewable energy storage market and progress with the CERENERGY project.
Read More
17Feb
Market update with Shaw and Partners, February 2023
17 Feb 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses financial conditions, the outlook for growth, central bank monetary policy, and what this means for portfolio construction.
Read More
06Sep
Paragon Care (ASX:PGC) FY21 results & outlook
06 Sep 2021 - Paragon Care Limited (ASX:PGC) CEO Phil Nicholl provides an update on FY21 results, which reported growth in all key financial metrics and the recommencement of dividends.
Read More
04Oct
Knosys (ASX:KNO) discusses FY22 results
04 Oct 2022 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY22 highlights, revenue drivers, growth investments, hybrid working tailwinds and the outlook for FY23.
Read More
06Apr
LaserBond (ASX:LBL) specialist surface engineering
06 Apr 2021 - LaserBond Limited (ASX:LBL) CEO Wayne Hooper talks about the company's strong 1H21 results despite the impact of COVID-19, its focus on growth opportunities to expand its national footprint, and business strategy, including potential growth via acquisitions.
Read More
28Aug
Chimeric Therapeutics (ASX:CHM) – bringing cell therapy to more patients with cancer, August 2021
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
23Jul
Noxopharm (ASX:NOX) – Converting “cold” cancer tumours to “hot” tumours
23 Jul 2020 - Noxopharm Limited (ASX:NOX) Executive Chairman and CEO Dr Graham Kelly discusses important pre-clinical results for the company's programs.
Read More